SIRT1激动剂通过降低ACAT1表达抑制平滑肌泡沫细胞形成

王旭; 陈雪; 孙梦姣; 张明杰; 郭露; 朱洁; 李敬诚; 张莉莉

doi:10.16016/j.1000-5404.201611076

您当前的位置：

首页 >

文章列表页 >

SIRT1激动剂通过降低ACAT1表达抑制平滑肌泡沫细胞形成

基础医学 | 更新时间：2026-01-09

- SIRT1激动剂通过降低ACAT1表达抑制平滑肌泡沫细胞形成
- SIRT1 agonist inhibits smooth muscle foam cell formation by decreasing ACAT1 expression
- 第三军医大学学报 2017年39卷第9期页码：846-851
- 作者机构：
- 作者简介：
- 基金信息：
  
  国家自然科学基金面上项目(81471193);成都军区总医院青年科技创新人才计划(2016KC01)
- DOI：10.16016/j.1000-5404.201611076
  中图分类号：
- 收稿：2016-11-16，
  
  纸质出版：2017-05-15
- 稿件说明：
移动端阅览
王旭, 陈雪, 孙梦姣, 等. SIRT1激动剂通过降低ACAT1表达抑制平滑肌泡沫细胞形成[J]. 第三军医大学学报, 2017,39(9):846-851.

Xu Wang, Xue Chen, Mengjiao Sun, et al. SIRT1 agonist inhibits smooth muscle foam cell formation by decreasing ACAT1 expression[J]. Journal of Third Military Medical University, 2017, 39(9): 846-851.
王旭, 陈雪, 孙梦姣, 等. SIRT1激动剂通过降低ACAT1表达抑制平滑肌泡沫细胞形成[J]. 第三军医大学学报, 2017,39(9):846-851. DOI： 10.16016/j.1000-5404.201611076.

Xu Wang, Xue Chen, Mengjiao Sun, et al. SIRT1 agonist inhibits smooth muscle foam cell formation by decreasing ACAT1 expression[J]. Journal of Third Military Medical University, 2017, 39(9): 846-851. DOI： 10.16016/j.1000-5404.201611076.

摘要

Abstract

Objective

To determine the effect of silent information regulation 2 homolog-1 (SIRT1) on foam cell formation in vascular smooth muscle cell (VSMC) after the inducement of oxidized low density lipoprotein (ox-LDL) and investigate the underlying mechanisms.

Methods

Primary VSMC were isolated from the aorta of male C57BL/6J mice and identified by immunofluorescence staining. The VSMC-derived foam cell formation was induced by the stimulation of 80 μg/mL ox-LDL for 24

48 or 72 h. The expression profile of SIRT1 was measured in the process of foam cell formation. SIRT1 agonist SRT1720 (SRT

1 μmol/L) and its antagonist nicotinamide (Nic

100 μmol/L) were used as well. Western blotting was employed to measure the protein expression levels of peroxisome proliferator-activated receptor gamma (PPARγ) and acyl-coenzyme a: A-cholesterol acyltransferase 1 (ACAT1). Oil red O staining was used to detect intracellular lipid deposition and foam cell formation. PPARγ agonist rosiglitazone (RSG

50 μmol/L) and its inhibitor GW9662 (10 μmol/L) were used to manipulate the activity of PPARγ

and their effects on the expression of ACAT1 were detected by Western blotting.

Results

① The expression of SIRT1 in VSMC-derived foam cells was reduced approximately by 47% after 48 hours'

ox-LDL incubation (

0.01). Oil red O staining showed that SRT+ox-LDL treatment inhibited the formation of VSMC-derived foam cells

while the stimulation of SIRT1 antagonist Nic reversed such effect. ② The expression level of ACAT1 was enhanced in the VSMC-derived foam cells (2.77±0.70

0.01)

which could be counteracted by SRT (0.90±0.27

0.01). However

Nic stimulation resulted in block in the inhibition and enhanced the expression of ACAT1 (2.25±0.37

0.05). ③ The expression of PPARγ was decreased in the VSMC after ox-LDL stimulation (0.73±0.09

0.01). SIRT1 agonist SRT significantly up-regulated the expression (0.98±0.16

0.05)

while Nic down-regulated (0.47±0.13

0.01). ④ PPARγ agonist RSG suppressed the expression of ACAT1 in VSMC-derived foam cells (0.73±0.09

0.01)

while the inhibitor GW9662 increased the expression (1.68±0.09

0.01).

Conclusion

SIRT1 inhibits the expression of ACAT1 induced by ox-LDL through up-regulating PPARγ

and thus ultimately suppresses the foam cell formation in VSMC.

关键词

Keywords

references

Allahverdian S Chehroudi A C McManus B M Contribution of intimal smooth muscle cells to cholesterol accumulation and macrophage-like cells in human atherosclerosis Circulation 2014 129 15 1551 1559 10.1161/CIRCULATIONAHA.113.005015 Allahverdian S, Chehroudi A C, McManus B M, et al. Contribution of intimal smooth muscle cells to cholesterol accumulation and macrophage-like cells in human atherosclerosis[J]. Circulation, 2014, 129 (15): 1551-1559.DOI:10.1161/CIRCULATIONAHA.113.005015.

Winnik S Auwerx J Sinclair D A Protective effects of sirtuins in cardiovascular diseases from bench to bedside Eur Heart J 2015 36 48 3404 3412 10.1093/eurheartj/ehv290 Winnik S, Auwerx J, Sinclair D A, et al. Protective effects of sirtuins in cardiovascular diseases from bench to bedside[J]. Eur Heart J, 2015, 36 (48):3404-3412.DOI:10.1093/eurheartj/ehv290.

Chong Z Z Wang S Shang Y C Targeting cardiovascular disease with novel SIRT1 pathways Future Cardiol 2012 8 1 89 100 10.2217/fca.11.76 Chong Z Z, Wang S, Shang Y C, et al. Targeting cardiovascular disease with novel SIRT1 pathways[J]. Future Cardiol, 2012, 8(1):89-100.DOI:10.2217/fca.11.76.

Feng S Reuss L Wang Y Potential of Natural Products in the Inhibition of Adipogenesis through Regulation of PPARgamma Expression and/or Its Transcriptional Activity Molecules 2016 21 10 1278 10.3390/molecules21101278 Feng S, Reuss L, Wang Y. Potential of Natural Products in the Inhibition of Adipogenesis through Regulation of PPARgamma Expression and/or Its Transcriptional Activity[J]. Molecules, 2016, 21(10):1278.DOI:10.3390/molecules21101278.

Chistiakov D A Bobryshev Y V Orekhov A N Macrophage-mediated cholesterol handling in atherosclerosis J Cell Mol Med 2016 20 1 17 28 10.1111/jcmm.12689 Chistiakov D A, Bobryshev Y V, Orekhov A N. Macrophage-mediated cholesterol handling in atherosclerosis[J]. J Cell Mol Med, 2016, 20(1): 17-28.DOI:10.1111/jcmm.12689.

Yin Y W Liao S Q Zhang M J TLR4-mediated inflammation promotes foam cell formation of vascular smooth muscle cell by upregulating ACAT1 expression Cell Death Dis 2014 5 e1574 10.1038/cddis.2014.535 Yin Y W, Liao S Q, Zhang M J, et al. TLR4-mediated inflammation promotes foam cell formation of vascular smooth muscle cell by upregulating ACAT1 expression[J]. Cell Death Dis, 2014, 5:e1574.DOI:10.1038/cddis.2014.535.

Allahverdian S Pannu P S Francis G A Contribution of monocyte-derived macrophages and smooth muscle cells to arterial foam cell formation Cardiovasc Res 2012 95 2 165 172 10.1093/cvr/cvs094 Allahverdian S, Pannu P S, Francis G A. Contribution of monocyte-derived macrophages and smooth muscle cells to arterial foam cell formation[J]. Cardiovasc Res, 2012, 95(2):165-172.DOI:10.1093/cvr/cvs094.

Zhang M J Zhou Y Chen L SIRT1 improves VSMC functions in atherosclerosis Prog Biophys Mol Biol 2016 121 1 11 15 10.1016/j.pbiomolbio.2016.02.003 Zhang M J, Zhou Y, Chen L, et al. SIRT1 improves VSMC functions in atherosclerosis[J]. Prog Biophys Mol Biol, 2016, 121(1):11-15.DOI:10.1016/j.pbiomolbio.2016.02.003.

Thompson A M Wagner R Rzucidlo E M Age-related loss of SirT1 expression Results in dysregulated human vascular smooth muscle cell function Am J Physiol Heart Circ Physiol 2014 307 4 H533 H541 10.1152/ajpheart.00871.2013 Thompson A M, Wagner R, Rzucidlo E M. Age-related loss of SirT1 expression Results in dysregulated human vascular smooth muscle cell function[J]. Am J Physiol Heart Circ Physiol, 2014, 307(4): H533-H541.DOI:10.1152/ajpheart.00871.2013.

Cheng G Zhang X Gao D Resveratrol inhibits MMP-9 expression by up-regulating PPAR alpha expression in an oxygen glucose deprivation-exposed neuron model Neurosci Lett 2009 451 2 105 108 10.1016/j.neulet.2008.12.045 Cheng G, Zhang X, Gao D, et al. Resveratrol inhibits MMP-9 expression by up-regulating PPAR alpha expression in an oxygen glucose deprivation-exposed neuron model[J]. Neurosci Lett, 2009, 451(2):105-108.DOI:10.1016/j.neulet.2008.12.045.

Cardellini M Menghini R Martelli E TIMP3 is reduced in atherosclerotic plaques from subjects with type 2 diabetes and increased by SirT1 Diabetes 2009 58 10 2396 2401 10.2337/db09-0280 Cardellini M, Menghini R, Martelli E, et al. TIMP3 is reduced in atherosclerotic plaques from subjects with type 2 diabetes and increased by SirT1[J]. Diabetes, 2009, 58 (10):2396-2401.DOI:10.2337/db09-0280.

Gorenne I Kumar S Gray K Vascular smooth muscle cell sirtuin 1 protects against DNA damage and inhibits atherosclerosis Circulation 2013 127 3 386 396 10.1161/CIRCULATIONAHA.112.124404 Gorenne I, Kumar S, Gray K, et al. Vascular smooth muscle cell sirtuin 1 protects against DNA damage and inhibits atherosclerosis[J]. Circulation, 2013, 127(3):386-396.DOI:10.1161/CIRCULATIONAHA.112.124404.

Yu X H Fu Y C Zhang D W Foam cells in atherosclerosis Clin Chim Acta 2013 424 245 252 10.1016/j.cca.2013.06.006 Yu X H, Fu Y C, Zhang D W, et al. Foam cells in atherosclerosis[J]. Clin Chim Acta, 2013, 424:245-252.DOI:10.1016/j.cca.2013.06.006.

He P Mei C Cheng B Chlamydia pneumoniae induces macrophage-derived foam cell formation by up-regulating acyl-coenzyme A:cholesterol acyltransferase 1 Microbes Infect 2009 11 2 157 163 10.1016/j.micinf.2008.11.001 He P, Mei C, Cheng B, et al. Chlamydia pneumoniae induces macrophage-derived foam cell formation by up-regulating acyl-coenzyme A:cholesterol acyltransferase 1[J]. Microbes Infect, 2009, 11(2):157-163.DOI:10.1016/j.micinf.2008.11.001.

Wang S Moustaid-Moussa N Chen L Novel insights of dietary polyphenols and obesity J Nutr Biochem 2014 25 1 1 18 10.1016/j.jnutbio.2013.09.001 Wang S, Moustaid-Moussa N, Chen L, et al. Novel insights of dietary polyphenols and obesity[J]. J Nutr Biochem, 2014, 25(1):1-18.DOI:10.1016/j.jnutbio.2013.09.001.

Voloshyna I Hai O Littlefield M J Resveratrol mediates anti-atherogenic effects on cholesterol flux in human macrophages and endothelium via PPARgamma and adenosine Eur J Pharmacol 2013 698 1/2/3 299 309 10.1016/j.ejphar.2012.08.024 Voloshyna I, Hai O, Littlefield M J, et al. Resveratrol mediates anti-atherogenic effects on cholesterol flux in human macrophages and endothelium via PPARgamma and adenosine[J ] . Eur J Pharmacol, 2013, 698(1/2/3):299-309.DOI:10.1016/j.ejphar.2012.08.024.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

PPARδ通过下调ACAT1抑制血管平滑肌细胞泡沫样变

大胞饮途径介导血管平滑肌细胞内脂滴聚集

oxLDL通过PPARγ-ABCG1通路促进血管平滑肌细胞泡沫化

TLR4通过下调ABCA1表达促进平滑肌源性泡沫细胞形成

miR-145表达状态对大鼠高血压动脉内膜增生的影响